Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Melatonin on Depression, Anxiety, Cognitive Function and Sleep Disturbances in Breast Cancer Patients

NCT01355523 is registered in ClinicalTrials.gov with Melissa Voigt Hansen as lead sponsor.

NCT NCT01355523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01355523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Melatonin on Depression, Anxiety, Cognitive Function and Sleep Disturbances in Breast Cancer Patients
Lead sponsor
Melissa Voigt Hansen
Phase
Phase 2/3
Overall status
Terminated
Start date
July 31, 2011
Completion date
January 31, 2013
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, depression